Compass Therapeutics Inc.
Compass Therapeutics Inc.

Compass Therapeutics Inc. Information

Contact top employees from Compass Therapeutics Inc.

Summary

Compass Therapeutics Inc. is a public company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO is occupied by Thomas J. Schuetz. Its headquarters is located at Boston, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Compass Therapeutics Inc. varies between 5.0M and 25M. Total funding of the company - $291.6M. To connect with Compass Therapeutics Inc. employee register on SignalHire.

Organization Website

compasstherapeutics.com

Social Links

linkedInfacebooktwitter

Phone Number

1-617-500-8099

Industries

Headquarters Location

80 Guest Street, Boston, MA, 02135 US

Employees Size

10-50 employees

Specialties

Drug Discovery and Development, Biologics, Oncology, Immuno-Oncology

SIC Code

2836

DMA Code

Greater Boston

Founded

2014

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
1997Public
Company
250 - 500 < 1M $258.6M
2013Public
Company
1.0K - 5.0K 106M $1.5B
1999Public
Company
100 - 250 79.4M $141.4M
2010Privately
Held
25 - 100 7.1M $158M

Estimated Website Traffic

The chart shows a decline in traffic to the compasstherapeutics.com website. In November, traffic decreased to 2681, compared to 2716 in the previous month. The highest traffic in 2025 was recorded in October, reaching 2716 visits.

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Compass Therapeutics Inc. shows a diverse range of experience levels:
5% have been with the company for less than 1 year14% for 1–2 years10% for 3–4 years29% for 5–7 years29% for 8–10 years14% have over 11 years of service at Compass Therapeutics Inc.
Ex-employees positions
In Company
In New Company
Contact top employees from Compass Therapeutics Inc.
Ian Chia
Vice President of Business Development & Strategy
View
Kris Sachsenmeier
Vice President, Head of Translational Science
View
James Kranz
Vice President and Head of CMC
View
Greg Zarbis
VP Process & Manufacturing
View
Kun Po Li
Postdoctoral Researcher
View
Sarah Zuerndorfer
Senior Associate Scientist
View
Barry Shin
Chief Financial Officer
View
Elisabeth Swanholm
Operations Manager
View
Nicole Gampp
Senior Alliance Manager, Business Development
View
Kelly Ocasio
Senior Clinical Trial Associate
View
Rich Lindahl
Board Member
View
Sumita
Senior Clinical Consultant Clinical Operations
View
Loueyee Elbusefi
Biotechnology Research
View
Aude Thiriot
Senior Scientist
View
Feny Gunawan
Director of CMC
View
Li Chen
Director CMC and MSAT
View
Neal Schilling
Director - Manufacturing
View
Alberto Visintin
Sr. Director - Translational Research
View
Sarah Pilgrim
Senior Clinical Trial Manager
View
Tristan Lubinski
Bioinformatics Lead
View
Ruby Piña Mimbela
Senior Associate Scientist
View
Patrick ONeill
Senior Accounting Manager
View
Raul Alejandro
Finance Manager
View
Varsha Menon
Director of Biometrics
View
Anna Gifford
Chief of Staff
View
Diana Albu
Associate Director
View
Rachael Duffy
Associate Scientist II
View
Mara Shainheit
Director - Translational Science
View
Natalie Warholic
Director, Clinical Operations
View

FAQ

Compass Therapeutics Inc. operates in the Biotech industries. More details can be found on the official website: compasstherapeutics.com.
The headquarters of Compass Therapeutics Inc. are located in Boston, United States.
The current CEO of Compass Therapeutics Inc. is Thomas J. Schuetz
You can contact Compass Therapeutics Inc. by phone at 1-617-500-8099.
Compass Therapeutics Inc. currently employs 10-50 people.
Compass Therapeutics Inc.'s revenue is approximately 8.5M.
Well-known competitors of Compass Therapeutics Inc. include Arena Pharmaceuticals, Inc., Juno Therapeutics, Inc., Innate Pharma and Apexigen.
BACK TO TOP